Embodiments of dermatological cell treatment are described generally herein. Other embodiments may be described and claimed.

The present invention provides an acumoxa therapy device utilizing energy waves for preventing, alleviating or treating COVID-19 (SARS-CoV-2) coronavirus infection. In one embodiment, the device delivers energy in a non-invasive manner. In one embodiment, the device is configured to include an energy pin and one or more energy rings. In one embodiment, the device delivers sufficient energy to certain body parts such as acupoints to achieve an intervening and/or therapeutic effect. In one embodiment, the device can maintain or improve general health, or can alleviate or treat a subject with COVID-19 infection and one or more other conditions. In one embodiment, the present invention also discloses a system comprising the device and uses thereof.

A kit for discharging electrons from a human comprises at least two electrically conductive electrodes. The electrodes are adapted for creating an electrical connection with skin of the human. There is an electrically conductive pad with electrically conductive pad wires, one for each electrode for connection to the respective electrode to the pad. Electrically conductive grounding wire is provided for electrically grounding the pad. The kit can comprise electrically conductive gel for use with the electrodes to enhance electrically conductivity. The kit is designed, when assembled and used to treat a human, for withdrawing excess electrons from the human for improved health.

The present invention relates to a negative pressure device, including: a hollow needle assembly including: a hollow needle adaptor, the hollow needle adaptor has an axial through hole, a proximal connector, a distal connector and a flange between the proximal connector and the distal connector, and at least one hollow needle, each of the at least one hollow needle has a tip and an axial through hole and is in fluid communication with the proximal connector of the hollow needle adaptor; a host machine, the host machine includes a control module and a vacuum pump; and an exhaust pipe, the exhaust pipe is in fluid communication with the host machine and the distal connector of the hollow needle adaptor.

This implantation device includes: a set of separable implants, a guide member defining a passage for guiding the set of implants in translation towards the outlet orifice, a transmission member for transmitting a pushing force in order to move the set of implants towards an outlet, the transmission member having several successive projections, and a pushing member to allow the practitioner to generate the pushing force. The pushing member includes a bearing part configured to bear against several of the projections during successive movements of the pushing member, the bearing part having in succession a bearing position and a clearing position, and a unidirectional stop element connected to the guide member and configured to have in succession i) a configuration of clearance by a projection and ii) a stop configuration so as to immobilize the transmission member in the inverse direction of the translation towards the outlet.

A method is provided for a novel application of trigger point dry needling. A target tissue is identified based on the observation of a series of movement patterns performed by the patient. Once identified, a needle movement protocol is used to insert a needle into the target tissue to a myofascial trigger point during one or more movement patterns. The needle protocol is adjusted until a local twitch response is induced.

Provided herein, in some embodiments, are methods that include electro stimulating at least one acupoint in a subject, isolating from a blood sample obtained from the subject cells that are immunocytochemically positive for CD 146 (CD146+), and administering to the subject a pharmaceutical composition of cells comprising non-cultured CD146+ stem cells. Also provided herein are pharmaceutical composition and kits comprising the non-cultured CD146+ stem cells.

An efficient spontaneous electrochemical current interacting press needle that relates to an acupuncture press needle of traditional Chinese medicine is provided. The efficient spontaneous electrochemical current interacting press needle includes a press needle and a conductive medical tape that fixes the press needle and attaches other press needles. The conductive medical tape includes a conductive adhesive and a gummed cloth. The press needle is adapted to be fixed on the conductive medical tape that fixes the press needle and attaches other press needles. In addition, a connecting conductive medical tape and/or an external conductor connecting point that is capable of attaching two or more press needles is also provided.

A device that uses an anatomic landmark or fiduciary point to establish a point of origin for device orientation in space is provided. The device controls the direction and depth of delivery of a needle, wire, trocar or cannula utilized for diagnostic or therapeutic intervention. The device guides the percutaneous delivery of a needle, wire, trocar or cannula to a target spatial location on or within tissue.

Devices and methods for generating and applying stimulated acupuncture needles to one or more acupuncture points on a body of an individual suffering from one or more ailments using magnetic fields. The acupuncture device is configured for generating magnetic fields to stimulate acupuncture without using human manual manipulation. The acupuncture device may comprise a control unit and one or more acupuncture needle stimulation units. Each one or more acupuncture needle stimulation unit is functionally connected to the control unit by a cable or lead. The control unit may include a variable frequency generator configured to deliver various power levels, direct voltages, or a combination of various power levels and direct voltages to the acupuncture needle stimulation units, alone or in combination with other stimuli.